Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for... see more

Recent & Breaking News (CSE:AION)

Aion Therapeutic Announces Closing of Toppen Health Inc. Acquisition

Newsfile December 15, 2023

Aion Therapeutic Announces Definitive Agreement to Acquire Toppen Health Inc.

Newsfile October 23, 2023

Canadian Investment Regulatory Organization Trading Halt - AION

Canada NewsWire October 19, 2023

Aion Therapeutic Announces Closing of Second Tranche of Non-Brokered Private Placement Offering of Units

Newsfile October 5, 2023

Aion Therapeutic Announces Second Tranche of Non-Brokered Private Placement Offering of Units

Newsfile September 8, 2023

Aion Therapeutic Announces Closing of Non-Brokered Private Placement Offering of Units

Canada NewsWire August 14, 2023

Aion Therapeutic Announces Director Resignation

Canada NewsWire July 6, 2023

Canadian Investment Regulatory Organization Trade Resumption - AION

Canada NewsWire July 4, 2023

Aion Therapeutic Announces Proposed Non-Brokered Private Placement Offering of Units

Canada NewsWire July 4, 2023

Canadian Investment Regulatory Organization Trading Halt - AION

Canada NewsWire July 4, 2023

Aion Therapeutic Files Financials

Newsfile November 7, 2022

Aion Therapeutic Provides Default Status Update

Newsfile October 25, 2022

Aion Therapeutic Provides Default Status Update

Newsfile October 11, 2022

Aion Therapeutic Provides Default Status Update

Newsfile September 26, 2022

Aion Therapeutic Provides Default Status Update

Newsfile September 13, 2022

Aion Therapeutic Reports Delay in Filing 2022 Annual Financial Statements

Newsfile August 30, 2022

Aion Therapeutic Reports Delay in Filing 2022 Annual Financial Statements

Newsfile August 18, 2022

Aion Therapeutic Announces Intellectual Property Sale and Management and Board Changes

Newsfile June 30, 2022

Aion Therapeutic Files Financials

Newsfile November 2, 2021

Aion Therapeutic Provides Default Status Update

PR Newswire October 12, 2021